•
TE
TENX
Tenax Therapeutics, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
97.09M
Volume
187.13K
52W High
$18.38
52W Low
$4.63
Open
$0.00
Prev Close
$16.42
Day Range
0.00 - 0.00
About Tenax Therapeutics, Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
Latest News
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire Inc.•Aug 28
Plastic Fencing Market to be Driven by Growing Residential and Commercial Construction Activities, Exclusive Research by The Insight Partners
GlobeNewswire Inc.•Mar 19
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
GlobeNewswire Inc.•Jan 31
Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care
Benzinga•Jan 28
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
GlobeNewswire Inc.•Jan 14
Behavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest Technology
GlobeNewswire Inc.•Nov 22
Ensign Adds 8 Facilities in Kansas & Colorado to Expand Footprint
Benzinga•Sep 5
Europe Pavement Reinforcement Materials (Carbon Fiber, Glass Fiber, Steel Rebar) Industry Analysis Report 2024-2030
GlobeNewswire Inc.•Aug 20